GL at a glance
Globe Life (GL, SEC CIK 320335) filed its latest 10-K annual report on February 25, 2026, a 10-Q quarterly report on August 5, 2026, an 8-K current report on August 7, 2026 and Form 4 insider filings as recently as September 23, 2026. SignalX summarizes each filing with AI and tracks the company's insider trades and institutional holders.
- For the fiscal year ended December 31, 2025 (FY2025), Globe Life (GL) reported revenue of $6.0 billion (up 3.7% from FY2024) and net income of $1.2 billion. Diluted EPS was $14.07.
- As of June 30, 2026, 35 institutional investment managers tracked by SignalX reported holding Globe Life (GL) shares worth $6.5 billion in 13F-HR filings.
- The most recent insider open-market sale reported on Form 4 was by Hensley Robert Edward on September 22, 2026 of 6,656 shares at $170.34 per share.
- In the last 90 days, GL insiders reported 0 open-market purchases ($0) and 16 open-market sales ($30.0M) on Form 4, a net sale of $30.0M.
Source: SEC EDGAR (XBRL financial data, 13F-HR and Form 4 filings).
- Revenue · FY2025
- $6.0B
- +3.7% vs prior year
- Insiders · 90 days
- 0 buys · 16 sells
- Net −$30.0M
- 13F holders
- 35 funds
- $6.5B · −1 vs prior quarter
- Latest 8-K
- Aug 7, 2026
- Item 5.02
AI 10-K Annual Report Analysis
Latest 10-K, fiscal year ended Dec 31, 2025
Risk Factors
- Legal proceedings costs $13.5M in 2025 and $17M in 2024, indicating ongoing material litigation exposure with no specific resolution timeline
- Excess investment income fell 16% to $138M in 2025, driven by lower yields on commercial mortgage loans and limited partnerships and constrained asset growth
- American Income Life Division contributes 53% of total life premium ($1.79B), creating heavy single-channel concentration risk
- Medicare Advantage market shift boosted United American health net sales 92%, but underwriting margin compressed to 6% from 8% due to rising claims utilization
- Fixed maturity portfolio 42% BBB-rated at $18.8B amortized cost, with $1.2B net unrealized loss position and effective duration of 8.7 years to next call
Management Discussion & Analysis
- Total premium $4.9B, up 5% YoY; life premium $3.4B (+3%), health premium $1.5B (+9%)
- Net income $1.16B vs $1.07B; net operating income ROE (ex-AOCI) 16.0% vs prior-year mid-teens target
- Best segment: life underwriting margin $1.51B, 45% of premium vs 41% in 2024; worst: excess investment income $138M, down 16% YoY
- Share repurchases 5.4M shares at $685M avg $126.41/share; quarterly dividend raised to $0.27 in 2025, projected $0.33 in 2026
- 2026 subsidiary dividends and excess cash flows projected lower due to nonrecurring extraordinary dividends of $272M received in 2024–2025
Business Overview
- Insurance holding company selling life and supplemental health products to lower-middle-income Americans via direct-to-consumer and exclusive agent channels
- Established Globe Life Re Ltd. in Bermuda in 2025: new affiliated reinsurer registered as Class C insurer under BMA supervision for capital efficiency
- Health insurance annualized premium in force grew to $1.65B in 2025 vs $1.48B in 2024, driven by United American Medicare Supplement (+$125.7M) and Family Heritage (+$41M)
- 3,695 employees (1% decrease YoY); 17,000+ independent contracted agents across U.S., Canada, and New Zealand
- $8M+ in charitable contributions in 2025, focused on children, families, veterans, and seniors
AI summary of the GL 10-K filed . Generated from the filing text; verify against the original.View on SEC EDGARHow to read a 10-K
AI 10-Q Quarterly Report Analysis
Latest 10-Q, quarter ended Jun 30, 2026
Management Discussion & Analysis
- Six-month revenue: total premium $2.6B, up 6% YoY from $2.4B
- Net income $558M vs $507M; operating income $558M vs $530M
- Life margin 41% vs 41%; health margin 23% vs 24%
- Health best growth: premium $854M, up 14%; DTC life worst sales, down 4% to $54M
- Repurchased 2.6M shares for $378M; DTC facing AI-driven search headwinds
Risk Factors
- No material changes to risk factors since the most recent 10-K
- Credit facility amended June 26, 2026 through a Third Amended and Restated Credit Agreement
- Term-loan terms amended June 26, 2026 through an Amended and Restated Term Loan Agreement
- Share repurchases totaled 1,740,683 shares during April–June 2026
- No director or officer adopted or terminated a Rule 10b5-1 trading arrangement during six months ended June 30, 2026
AI summary of the GL 10-Q filed . Generated from the filing text; verify against the original.View on SEC EDGAR10-K vs 10-Q vs 8-K
AI 8-K Current Report Analysis
The most recent material events, by 8-K item
Item 5.02: Departure/Appointment of Directors or Principal Officers
- David A. Rodriguez retired from Globe Life’s Board effective August 4, 2026
- Departure attributed to personal reasons, not disagreement over operations, policies, or practices
Item 2.02: Results of Operations and Financial Condition
- Globe Life announced second-quarter 2026 financial results on July 22, 2026
- Detailed results, operating metrics, and management commentary are contained in Exhibit 99.1
Item 1.01: Entry into a Material Definitive Agreement
- Credit facility maturity extended from March 29, 2029 to June 26, 2031
- Administrative agent and related roles transferred from Bank of America to Wells Fargo
AI summaries of GL 8-K current reports filed with the SEC. What 8-K item codes mean
SignalX for GL
Don't miss the next GL filing
- Alerts as it files. A push when GL files an 8-K or an insider trades.
- Fund moves. Which tracked funds opened, added or cut GL, by share count.
- Ask anything. An AI agent that reads every GL filing and answers with sources.
GL alerts on your phone. Follow it in the SignalX Android app.
Recent Insider Transactions (Form 4)
Latest reported trades by officers, directors and 10% owners
| Insider | Type | Date | Shares | Price |
|---|---|---|---|---|
| Hensley Robert Edward | M | Sep 22, 2026 | 10,000 | - |
| Hensley Robert Edward | Sell | Sep 22, 2026 | 6,656 | $170.34 |
| Hensley Robert Edward | M | Sep 22, 2026 | 10,000 | $103.23 |
| Hensley Robert Edward | Sell | Sep 22, 2026 | 3,344 | $169.53 |
| MITCHELL ROBERT BRIAN | M | Aug 7, 2026 | 23,000 | - |
| MITCHELL ROBERT BRIAN | Sell | Aug 7, 2026 | 1,017 | $184.75 |
| MITCHELL ROBERT BRIAN | Sell | Aug 7, 2026 | 11,454 | $182.77 |
| MITCHELL ROBERT BRIAN | M | Aug 7, 2026 | 23,000 | $103.23 |
Financial SummaryXBRL
| Metric | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
| Profitability | |||
| Revenue | $5.4B | $5.8B | $6.0B |
| Gross Profit | $1.3B | - | - |
| Operating Income | $1.3B | - | - |
| Net Income | - | $1.1B | $1.2B |
| Gross Margin | 23.1% | - | - |
| Op. Margin | 23.2% | - | - |
| Net Margin | - | 18.5% | 19.4% |
| Balance Sheet | |||
| Total Assets | $28.1B | $29.1B | $30.8B |
| Equity | - | $5.3B | $6.0B |
| ROE | - | 20.2% | 19.4% |
| Per Share | |||
| EPS | - | $11.94 | $14.07 |
| Cash Flow | |||
| Operating CF | $1.5B | $1.4B | $1.4B |
| CapEx | $49.6M | $71.0M | $142.5M |
Source: XBRL data in Globe Life (GL)'s 10-K filings on SEC EDGAR, in USD. Compare across companies →
13F Fund Holdings: Quarterly Trend
Latest: Q2 2026Aggregate GL share value held by 13F filers tracked by SignalX, by quarter.
Quarterly totals table
| Quarter | Funds | Total value |
|---|---|---|
| Q2 2026 | 35 | $6.53B |
| Q1 2026 | 36 | $4.92B |
| Q4 2025 | 34 | $4.90B |
| Q3 2025 | 36 | $5.31B |
| Q2 2025 | 35 | $4.57B |
| Q1 2025 | 33 | $3.95B |
| Q4 2024 | 30 | $3.01B |
| Q3 2024 | 24 | $1.63B |
- Invesco Ltd+602.9K (+15%)
- AQR Capital Management+318.1K (+27%)
- FMR LLC (Fidelity)+216.9K (+21%)
- Two Sigma Investments+204.4K (+197%)
- State Street Corp+76.7K (+2%)
- Citadel Advisors LLC−126.9K (-50%)
- Franklin Resources−94.6K (-33%)
- Vanguard Portfolio Management LLC−72.5K (-2%)
- Vanguard Capital Management LLC−69.3K (-1%)
- Regions Financial Corporation−31.4K (-4%)
- Soros Fund Management−59.7K
Source: 13F-HR filings on SEC EDGAR (aggregated from 263 fund-quarter rows). Reflects only 13F filers tracked by SignalX, not the full institutional ownership universe. How 13F filings work
GL filing archive
AI analysis pages for each 10-K, 10-Q and 8-K
10-K annual reports
10-Q quarterly reports
Latest 2026 SEC Filings: 10-K, 10-Q, 8-K & Form 4
| Form | Filing date | Period | Analysis | SEC |
|---|---|---|---|---|
| 4 | Sep 23, 2026 | - | - | - |
| 4 | Aug 10, 2026 | - | - | - |
| 8-K | Aug 7, 2026 | - | Analysis | - |
| 10-Q | Aug 5, 2026 | Jun 30, 2026 | Analysis | |
| 13F-HR | Aug 3, 2026 | Jun 30, 2026 | - | |
| 4 | Aug 3, 2026 | - | - | - |
| 4 | Jul 30, 2026 | - | - | - |
| 4 | Jul 30, 2026 | - | - | - |
| 4 | Jul 29, 2026 | - | - | - |
| 8-K | Jul 22, 2026 | - | Analysis | - |
| 4 | Jun 30, 2026 | - | - | - |
| 8-K | Jun 29, 2026 | - | Analysis | - |
| 4 | Jun 26, 2026 | - | - | - |
| 4 | Jun 22, 2026 | - | - | - |
| 4 | Jun 16, 2026 | - | - | - |
| 4 | Jun 16, 2026 | - | - | - |
| 4 | Jun 15, 2026 | - | - | - |
| 4 | May 29, 2026 | - | - | |
| 4 | May 20, 2026 | - | - | |
| 4 | May 12, 2026 | - | - | |
| 13F-HR | May 11, 2026 | Mar 31, 2026 | - | |
| 10-Q | May 7, 2026 | Mar 31, 2026 | Analysis | |
| 4 | May 7, 2026 | - | - | |
| SC 13G | May 6, 2026 | - | - | |
| 4 | May 6, 2026 | - | - |
Related Financials companies
- BHF · Brighthouse Financial IncLife Insurance
- Canyon Capital AdvisorsLife Insurance
- CIA · CITIZENS, INC.Life Insurance
- CRBG · Corebridge Financial IncLife Insurance
- FG · F&G Annuities & Life, Inc.Life Insurance
- GNW · GENWORTH FINANCIAL INCLife Insurance
- JXN · Jackson Financial Inc.Life Insurance
- LNC · Lincoln National CorpLife Insurance
GL SEC filings: frequently asked questions
Are GL insiders buying or selling?
In the last 90 days, Globe Life (GL) officers, directors and 10% owners reported no open-market purchases and 16 open-market sales worth $30.0 million by 5 insiders on Form 4. Many insider sales are pre-planned or for taxes, so purchases usually carry more information.
Which institutions hold GL stock?
As of June 30, 2026, the largest Globe Life (GL) holders among the 13F filers tracked by SignalX were BlackRock ($987.9 million), Vanguard Capital Management LLC ($907.8 million), Invesco Ltd ($825.4 million), Vanguard Portfolio Management LLC ($747.2 million), State Street Corp ($667.4 million). 13F-HR reports are filed up to 45 days after each quarter ends.
What was GL's revenue in fiscal year 2025?
For the fiscal year ended December 31, 2025 (FY2025), Globe Life (GL) reported revenue of $6.0 billion (up 3.7% from FY2024) and net income of $1.2 billion. Diluted EPS was $14.07. The figures come from the XBRL data in the 10-K.
What are the main risks in GL's latest 10-K?
In the 10-K filed February 25, 2026, Globe Life (GL) flagged: Legal proceedings costs $13.5M in 2025 and $17M in 2024, indicating ongoing material litigation exposure with no specific resolution timeline. Excess investment income fell 16% to $138M in 2025, driven by lower yields on commercial mortgage loans and limited partnerships and constrained asset growth. (AI summary of the Risk Factors section.)
What did GL report in its latest 8-K?
Globe Life (GL) filed an 8-K on August 7, 2026 reporting Item 5.02 (Departure/Appointment of Directors or Principal Officers). David A. Rodriguez retired from Globe Life’s Board effective August 4, 2026.
What are the latest GL SEC filings?
Globe Life (GL) filed its latest 10-K annual report on February 25, 2026, a 10-Q quarterly report on August 5, 2026, an 8-K current report on August 7, 2026 and a Form 4 insider filing on September 23, 2026.
What is GL's SEC CIK number?
Globe Life (GL)'s SEC Central Index Key (CIK) is 320335. EDGAR lists every GL filing under that number.
Ask anything about GL
The research agent reads GL's filings, financials, insider trades and 13F holders, then answers with sources.